Preparing for Gene Therapy Starts with Understanding Immunity – WFH
World Federation of Hemophilia – WFH shared a post on LinkedIn about a recent article by Hubert Darius J Daniel et al., published in Human Gene Therapy, adding:
“Preparing for gene therapy starts with understanding immunity.
This study examines baseline AAV antibody levels among people with and without hemophilia in India, informing screening approaches and access planning.”
Title: Total and Neutralizing Antibody Seroprevalence of Hepatotropic Adeno-Associated Virus Among Healthy and Hemophilia A or B Population from India
Authors: Hubert Darius J Daniel, Jaffar Farzana, Rajesh Kannangai, Sanjay Kumar, Kavitha M Lakshmi, Charnitkaur B Jashal, Hemant Dhamne, Varun Lahoti, Deepak Kanjwani, Aby Abraham, Kirsten Coleman, Arun Srivastava, Alok Srivastava, Asha Mary Abraham
More posts about World Federation of Hemophilia on Hemostasis Today.
-
Sep 26, 2026, 18:01Kalyan Roy: Blood Group Chimerism as a Rare Cause of ABO Discrepancy
-
Sep 26, 2026, 17:34Arwa Z. Al-Riyami: Join ISBT and Advance Your Career
-
Sep 26, 2026, 16:58Paul Whiteley: Iron Deficiency and Behavioral Problems in Children With Autism
-
Sep 26, 2026, 16:41Matthew Smeds: Management of Thoracic Endograft Thrombosis and Mesenteric Embolization
-
Sep 26, 2026, 16:04Isabelle Feldhaus: What the New ASH Iron Deficiency Guidance Means for Care
-
Sep 26, 2026, 15:55Francesca Palandri: The R-NAT Score Developed in Ruxolitinib-Treated MF Patients
-
Sep 26, 2026, 15:49Alex Ehsan: Antiphospholipid Syndrome – A Practical Guide
-
Sep 26, 2026, 15:42Michael Tadao Inouye: The Next Frontier in Genomic Population Health
-
Sep 26, 2026, 15:32Katariina Öörni: Familial Hypercholesterolaemia in Children Why Early Diagnosis Matters